CASC3 and Miyoshi myopathy: Our results revealed that the treatment of MM cells with BTZ triggered the activation of processes that increase cellular energy, such as oxidative phosphorylation (OXPHOS), the generation of precursor metabolites and energy and the ATP metabolic process, which may be crucial in the development of resistance to BTZ.